Skip to main content
Erschienen in: Neurological Sciences 1/2018

01.06.2018 | MIGRAINE PATHOGENESIS

Neurophysiology of migraine

verfasst von: Anna Ambrosini

Erschienen in: Neurological Sciences | Sonderheft 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Migraine is the most prevalent among disabling neurological disorders. In its episodic form, it is characterized by ictal phases alternating with periods of wellness, lasting from few to many days. Although many efforts have been made in the last decades to unravel what makes the migrainous brain susceptible to migraine attacks, no consistent and permanent structural disturbances have been found. Migraine pathophysiology is thus supposed to be originated by a central nervous system (CNS) dysfunction, where several neuronal structures play major or minor roles, such as the cerebral cortex, the brainstem (periaqueductal gray matter, aminergic nuclei), and both peripheral and central components of the trigeminovascular system. Clinical neurophysiology methods have been used since many years to study migraine pathophysiology, because they are versatile, non-invasive, easy to replicate also in a standard clinical setting, and relatively not much expensive. Almost every electrophysiological technique has been used, usually by applying more or less sophisticated analysis tools: electroencephalography, event-related potentials, evoked potentials (VEP, AEP, SEP, LEPs), magnetoencephalography, transcranial magnetic stimulation, and blink reflex. Among them, the tests that have provided the most relevant informations for the understanding of migraine pathophysiology are evoked potentials. By using the very simple ploy of analyzing the cortical evoked responses to repetitive external stimulations by consecutive block averages, instead of by a global average, every modality of stimulation—delivered in episodic migraine patients during the interictal period—showed a particular response pattern, which is a deficit of habituation of cortical responses to repeated stimuli. Normally, when a stimulus is delivered repetitively, the amplitude of cortical evoked potentials gradually decreases (i.e., habituates). This phenomenon, known as “habituation,” is supposed to protect the brain from sensory overload and to save attentional resources for meaningful and potentially dangerous novel stimuli. However, in episodic migraine sufferers, the amplitude of cortical responses remains unchanged or increases (i.e., potentiates) between attacks [1]. It has been demonstrated particularly by the mean of pattern-reversal visual evoked potentials, but it was successfully replicated also by the mean of auditory evoked potentials, somatosensory evoked potentials, laser evoked potentials, visual evoked magnetoencephalographic (MEG) responses, and also by tests where responses are not mediated at a cortical level, such as nociceptive trigeminal evoked responses. Surprisingly, the habituation of cortical responses normalizes just before and during the attack, and it shows a normal behavior in chronic migraine patients [2]. Although at the present no instrumental test is available for diagnosing migraine, this electrophysiologic pattern is so relevant and prevalent in migraineurs that it has been recently proposed as a possible diagnostic tool for episodic migraine [3]. …
Literatur
1.
Zurück zum Zitat de Tommaso M, Ambrosini A, Brighina F, Coppola G, Perrotta A, Pierelli F, Sandrini G, Valeriani M, Marinazzo D, Stramaglia S, Schoenen J (2014) Altered processing of sensory stimuli in patients with migraine. Nat Rev Neurol 10(3):144–155CrossRef de Tommaso M, Ambrosini A, Brighina F, Coppola G, Perrotta A, Pierelli F, Sandrini G, Valeriani M, Marinazzo D, Stramaglia S, Schoenen J (2014) Altered processing of sensory stimuli in patients with migraine. Nat Rev Neurol 10(3):144–155CrossRef
3.
Zurück zum Zitat Ambrosini A, Kisialiou A, Coppola G, Finos L, Magis D, Pierelli F, Schoenen J (2017) Visual and auditory cortical evoked potentials in interictal episodic migraine: an audit on 624 patients from three centres. Cephalalgia 37(12):1126–1134CrossRef Ambrosini A, Kisialiou A, Coppola G, Finos L, Magis D, Pierelli F, Schoenen J (2017) Visual and auditory cortical evoked potentials in interictal episodic migraine: an audit on 624 patients from three centres. Cephalalgia 37(12):1126–1134CrossRef
Metadaten
Titel
Neurophysiology of migraine
verfasst von
Anna Ambrosini
Publikationsdatum
01.06.2018
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe Sonderheft 1/2018
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-018-3385-3

Weitere Artikel der Sonderheft 1/2018

Neurological Sciences 1/2018 Zur Ausgabe

MIGRAINE AS A GENDER DISEASE

Gender differences in migraine

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.